Authors/Disclosures
|
Douglas Galasko, MD
(Dept. of Neurosciences, UCSD)
|
Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics. |
|
Fabio Nascimento, MD
(Washington University Medical School)
|
Dr. Nascimento has received publishing royalties from a publication relating to health care. |
|
Giulio M. Pasinetti, MD, PhD
(Mount Sinai School of Medicine)
|
No disclosure on file |
|
David P. Salmon, PhD
(Univ of Calif-San Diego)
|
Dr. Salmon has nothing to disclose. |
|
|
No disclosure on file |
|
John M. Olichney, MD
(Center for Mind and Brain)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Tritia R. Yamasaki, MD, PhD, FAAN
(University of Kentucky)
|
The institution of Dr. Yamasaki has received research support from Veteran's Affairs. The institution of an immediate family member of Dr. Yamasaki has received research support from Dept of Energy. |
|
Leon J. Thal, MD
(Dept of Neurosciences UCSD)
|
No disclosure on file |
|
Lisa Silbert, MD, FAAN
(OHSU)
|
The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH. |
|
|
No disclosure on file |
|
Jeffrey A. Kaye, MD, FAAN
(Oregon Hlth Sci Univ.)
|
Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Amy R. Borenstein, PhD, FAAN
|
No disclosure on file |